Health care providers, patients ignore FDA warnings about patches AmerisourceBergen opens Orlando DC after deal with FDA BlueCross/BlueShield of Oregon introduces new generics program Neruochem's Alzhemed fails phase III clinical trial Forest, Daiichi Sankyo sign agreement for Azor Exelixis cancer drug may bring large payment from GSK Teva receives final FDA approval for generic Famvir, but will delay marketing until patent hearing NACDS reminds parents to explore insurance possibilities for their children FDA considers privatizing 300 jobs NACDS bid to ease MedGuide rules gains a key supporter in U.S. Senate First Previous 2654 2655 2656 2657 2658 Next Last